Investigation of Site-Specific Differences in Glycan Microheterogeneity by N-Glycopeptide Mapping of VEGFR-IgG Fusion Protein
Open Access
Abstract
A biosimilar fusion protein VEGFR-IgG consisting of vascular endothelial growth factor receptors 1 and 2 (VEGFR-1, VEGFR-2) and the Fc portion of human IgG1 was prepared for this study. The prepared fusion protein was expected to possess a total of five N-linked glycosylation sites: two sites in the VEGFR-1 region, two sites in the VEGFR-2 region, and one site in the human IgG Fc region. For site-specific glycan analysis, the fusion protein was hydrolyzed with trypsin, and the resulting tryptic digests were analyzed by liquid chromatography–electrospray ionization tandem mass spectrometry (LC-ESI MS/MS). The expected N-linked glycosylation sites were successfully identified and site-specific glycopeptide mapping was completed by Integrated GlycoProteome Analyzer (I-GPA) for the resulting raw tandem mass data. Finally, it was clearly confirmed that N-linked glycans for each glycosylation site showed significantly different patterns in microheterogeneity, which may indicate certain functions for each glycosylation site in the protein. Based on the mapping results, the unique features in glycan microheterogeneity for the five glycosylation sites of VEGFR-IgG fusion protein were compared site-specifically and further discussed to understand the functional meaning of each glycosylation pattern.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2017R1D1A3B05029756)
This publication has 31 references indexed in Scilit:
- Pharmacokinetics of monoclonal antibodies and Fc-fusion proteinsProtein & Cell, 2017
- N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteinsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2016
- Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion ProteinsJournal of Pharmaceutical Sciences, 2015
- Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 2: Mass spectrometric methodsmAbs, 2015
- Biosimilars in oncology: current and future perspectivesGenerics and Biosimilars Initiative Journal, 2013
- Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography–mass spectrometry peptide mappingJournal of Chromatography A, 2011
- Monoclonal antibodies and fusion proteins and their complications: Targeting B cells in autoimmune diseasesJournal of Allergy and Clinical Immunology, 2010
- Glycan labeling strategies and their use in identification and quantificationAnalytical and Bioanalytical Chemistry, 2010
- Determination of glycosylation sites and site-specific heterogeneity in glycoproteinsCurrent Opinion in Chemical Biology, 2009
- The Impact of Glycosylation on the Biological Function and Structure of Human ImmunoglobulinsAnnual Review of Immunology, 2007